Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with standard chemotherapy. An analysis of patients with stage III colon patients ...

Please provide your email address to receive an email when new articles are posted on . Kidney transplant recipients with HIV who receive kidneys from deceased donors with HIV show positive overall ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2 nd - and 3 rd-line ...

Candel Therapeutics reports improved survival rates with CAN-2409 in pancreatic cancer, showcasing potential efficacy and a favorable safety profile. Positive final survival data showed a notable ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive long-term follow-up data from the pivotal, Phase III ...

SELLAS Life Sciences Group, Inc. announced positive overall survival results from their ongoing Phase 2 trial of SLS009 (tambiciclib) in patients with relapsed/refractory acute myeloid leukemia (AML), ...

Shares of ImmunityBio (NASDAQ:IBRX) rose as much as 17% premarket on Thursday after the biotech reported positive overall survival results from a trial evaluating its immunotherapy drug, Anktiva, in ...

The addition of pembrolizumab to neoadjuvant chemotherapy led to a significantly higher percentage of patients with early triple-negative breast cancer having a pathological complete response (defined ...

According to the American Cancer Society, breast cancer is the second leading cause of cancer in women. As the second leading cause of cancer, it is a serious concern. October is Breast Cancer ...

The CDK4/6 inhibitor FCN-437c plus letrozole for the treatment of HR+/HER2– advanced breast cancer: Updated results from a phase 1b study. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...